Younis Nancy S, Al-Harbi Nourah Yousef
1 Pharmaceutical sciences Department, College of Clinical Pharmacy, King Faisal University, Al-Hasa, Kingdom of Saudi Arabia.
2 College of Clinical Pharmacy, King Faisal University, Al-Hasa, Kingdom of Saudi Arabia.
Ther Innov Regul Sci. 2019 Sep;53(5):618-622. doi: 10.1177/2168479018807677. Epub 2018 Oct 31.
Acne vulgaris, a chronic inflammatory disease, is among the most common dermatologic conditions worldwide. In Saudi Arabia, Isotretinoin is commonly used to treat mild acne even without prescription.
To explore the practice and knowledge of community in Saudi Arabia regarding dispensing, counseling practices, and safety of isotretinoin-containing products.
A cross-sectional survey, using a self-administered questionnaire, was conducted in 3 sections: demographics, self-medication attitude (in the form of self Isotretinoin use), and identifying the side effects associated with the use of isotretinoin.
A total of 1069 participated in the study. Around half of the participants (44.2%) used isotretinoin with only mild acne as their first choice, which is contrary to the recommended guidelines. Virtually one-fifth of the participants did not examine the lipid profile, liver enzymes, and blood glucose level before isotretinoin use. Not many participants identified lipid (58.7%) and liver (44.1%) depression (53.3%), inflammatory bowel disease (75.9%), osteoporosis (60.3%), and sunburns (36.3%) as risks allied with isotretinoin use. Most participants (88.9%) appropriately recognized teratogenicity as the greatest hazard concomitant with the use of isotretinoin. Nevertheless, 20% of the women did not know that they must cease the drug at least 6 months before pregnancy.
This study shows that community residents are not satisfactorily aware of the proper use and jeopardies of isotretinoin. Therefore, greater consideration ought to be dedicated to augment the safe use of isotretinoin. We recommend the implementation of tools to enhance the safe use of isotretinoin and the imposition of more effective regulations to limit nonprescribed isotretinoin dispensing in Saudi Arabia.
寻常痤疮是一种慢性炎症性疾病,是全球最常见的皮肤病之一。在沙特阿拉伯,异维A酸即使没有处方也常用于治疗轻度痤疮。
探讨沙特阿拉伯社区在含异维A酸产品的配药、咨询做法及安全性方面的实践和知识。
采用自填式问卷进行横断面调查,调查分为三个部分:人口统计学、自我用药态度(以自我使用异维A酸的形式)以及识别与使用异维A酸相关的副作用。
共有1069人参与了该研究。约一半的参与者(44.2%)将异维A酸用于仅患有轻度痤疮的情况,且以此为首选,这与推荐指南相悖。实际上,五分之一的参与者在使用异维A酸前未检查血脂、肝酶和血糖水平。没有多少参与者将血脂(58.7%)和肝脏(44.1%)抑制(53.3%)、炎症性肠病(75.9%)、骨质疏松症(60.3%)以及晒伤(36.3%)识别为与使用异维A酸相关的风险。大多数参与者(88.9%)正确认识到致畸性是使用异维A酸时最大的危害。然而,20%的女性不知道她们必须在怀孕前至少6个月停药。
本研究表明,社区居民对异维A酸的正确使用和危害了解不足。因此,应更加重视提高异维A酸的安全使用。我们建议实施相关工具以加强异维A酸的安全使用,并实施更有效的法规来限制沙特阿拉伯非处方异维A酸的配药。